• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Isis Pharmaceuticals, Inc. (ISIS)

    -NasdaqGS
    51.54 Down 0.02(0.04%) Aug 28, 4:00PM EDT
    |After Hours : 51.60 Up 0.06 (0.12%) Aug 28, 5:59PM EDT
    Add to Portfolio
    Prev Close:51.56
    Open:51.24
    Bid:49.51 x 200
    Ask:51.71 x 400
    1y Target Est:65.00
    Beta:2.22577
    Earnings Date:Nov 5 - Nov 9 (Est.)
    Day's Range:50.50 - 52.20
    52wk Range:35.26 - 77.80
    Volume:1,532,851
    Avg Vol (3m):2,193,940
    Market Cap:6.18B
    P/E (ttm):271.26
    EPS (ttm):0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ISISDown 0.04%6.18B
    GILDDown 0.19%158.18B
    ENZUp 1.06%132.19M
    SRPTUp 1.27%1.52B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.83
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.52
    Quarterly EPS Est (Sep-15) :-0.31
    Mean Recommendation*:2.8
    PEG Ratio (5 yr expected):-4.31

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback